Clinical Trial Update: A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing montelukast with fluticasone in pediatric chronic asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone (fluticasone propionate)
• Montelukast (MK-0476) (montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Asthma, Bronchial | Phase 3 | Status: WITHDRAWN